urothelial cancer

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

Recruiting
  • Urothelial Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +196 more
Jan 17, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

Active, not recruiting
  • Urothelial Cancer
  • MEDI4736 (Durvalumab)
  • +4 more
  • Los Angeles, California
  • +221 more
Nov 2, 2022

Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:

Active, not recruiting
  • Urothelial Cancer
  • Avelumab
  • +2 more
  • Aurora, Colorado
  • +370 more
Oct 24, 2022

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab 800 mg in combination with pemetrexed / carboplatin
  • +3 more
  • Tucson, Arizona
  • +45 more
Oct 13, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

Urothelial Cancer Trial in Australia, Canada (Nab-Paclitaxel, Paclitaxel)

Completed
  • Urothelial Cancer
  • Douglas, Queensland, Australia
  • +36 more
Oct 28, 2020

Urothelial Cancer, Bladder Cancer, Adult Trial in Canada (SU011248, Placebo)

Completed
  • Urothelial Cancer
  • +2 more
  • Calgary, Alberta, Canada
  • +4 more
Aug 20, 2018